M.d. Anderson Cancer Center
Clinical trials sponsored by M.d. Anderson Cancer Center, explained in plain language.
-
New drug cocktail shows promise for tough blood cancers
Disease control Recruiting nowThis study tests a combination of four chemotherapy drugs (cladribine, idarubicin, cytarabine, and venetoclax) in people with acute myeloid leukemia, high-risk myelodysplastic syndrome, or a fast-growing form of chronic myeloid leukemia. The goal is to see how well these drugs ki…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 24, 2026 16:20 UTC
-
Heat treatment for thyroid tumors: tracking Long-Term results
Disease control Recruiting nowThis study follows patients who receive radiofrequency ablation (RFA), a minimally invasive heat treatment, for benign thyroid nodules or low-risk thyroid cancers. Researchers aim to track the long-term effectiveness of RFA and learn more about patients' quality of life after the…
Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 22, 2026 15:59 UTC
-
Laser vs. surgery: new battle against returning brain tumors
Disease control Recruiting nowThis study is testing whether adding focused radiation after surgery or laser heat therapy helps control recurrent brain metastases better than surgery/laser therapy alone. Researchers will compare two approaches: one group gets additional radiation after their procedure, while t…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 20, 2026 16:18 UTC
-
New cream combo tested against standard for skin cancer prevention
Disease control Recruiting nowThis study compares two topical cream treatments for people with multiple actinic keratoses, which are rough, scaly skin patches that can turn into skin cancer. Researchers want to see if adding calcipotriene cream to the standard fluorouracil cream works better at clearing these…
Phase: PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 13, 2026 20:21 UTC
-
New drug cocktail aims to shrink tumors before surgery
Disease control Recruiting nowThis study is testing whether a combination of three drugs—pembrolizumab, carboplatin, and paclitaxel—can effectively shrink tumors in people with early-stage triple-negative breast cancer before they have surgery. The goal is to see if this approach can completely eliminate canc…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 06, 2026 14:18 UTC
-
New imaging tool aims to make mouth biopsies more precise
Diagnosis Recruiting nowThis study tests a new imaging device called the Active Biopsy Guidance System. It helps doctors decide when and where to take tissue samples (biopsies) from suspicious mouth lesions. The goal is to see if the device can accurately identify which lesions need a biopsy, potentiall…
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Apr 24, 2026 16:19 UTC
-
Can a single drug stop lung cancer before it starts? new trial aims to find out
Prevention Recruiting nowThis study tests whether the drug canakinumab can prevent lung cancer in 50 people who have suspicious lung nodules that haven't gone away. Participants receive the drug and are monitored for nodule shrinkage, cancer development, and side effects. The goal is to see if this appro…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Prevention
Last updated Apr 23, 2026 12:45 UTC
-
Scientists building a 'Library' of lung samples to fight disease
Knowledge-focused Recruiting nowThis study aims to collect leftover fluid and tissue samples from routine lung procedures to create a research bank. The goal is to help scientists better understand and treat lung problems, especially those related to cancer treatments. Participants are adults already scheduled …
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Apr 13, 2026 20:21 UTC